SCHEMBL14933477

SCHEMBL14933477

O=c1c2ccccc2c2ccc3cccnc3c2n1-c1cc(-c2ccccc2)cc(-c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.40
CYP1A2 P05177 2/20 0.40
GAA P10253 2/20 0.40
CYP3A4 P08684 2/20 0.40
HPGD P15428 1/20 0.40
CYP2C9 P11712 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 3/20 0.39
HSP90AA1 P07900 2/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
FABP1 P07148 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
MAPK1 P28482 1/20 0.38
MMP2 P08253 2/20 0.37
LOXL3 P58215 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20633747 0.85 MAPT (0.38) CYP2C19CYP1A2GAACYP3A4HPGD
SCHEMBL16359138 0.83 FABP1 (0.32) CYP2C19CYP1A2GAACYP3A4HPGD
SCHEMBL14933482 0.76 MEN1 (0.41) CYP2C19GAACYP2C9MEN1KMT2A
SCHEMBL14933610 0.76 KMT2A (0.42) CYP2C19CYP2C9MEN1KMT2AMAPT
SCHEMBL18434418 0.74 CYP3A4 (0.47) CYP2C19CYP1A2GAACYP3A4HPGD
SCHEMBL13086927 0.73 LMNA (0.37) CYP2C19CYP3A4HPGDMEN1KMT2A
SCHEMBL14933480 0.73 MAPK1 (0.41) GAAMEN1KMT2AMAPTHSP90AA1
SCHEMBL14933341 0.70 KMT2A (0.53) CYP2C19CYP1A2CYP3A4HPGDCYP2C9
SCHEMBL14933485 0.70 CYP1A1 (0.40) CYP2C19CYP1A2GAACYP2C9MEN1
SCHEMBL13086750 0.70 KDM4E (0.36) CYP3A4HPGDMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO4C1, SLCO2A1 CYP2C19 16/4885CYP1A2 170/4885GAA 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.